We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-11.47%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$186M
AUM Growth
-$94.7M
Cap. Flow
-$67.3M
Cap. Flow %
-36.29%
Top 10 Hldgs %
37.92%
Holding
69
New
7
Increased
10
Reduced
25
Closed
21

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$6.04M
2
DHR icon
Danaher
DHR
+$4.61M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.66M
4
ELAN icon
Elanco Animal Health
ELAN
+$2.74M
5
SNN icon
Smith & Nephew
SNN
+$2.73M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$8.69M
2
AET
Aetna Inc
AET
+$7.1M
3
ALGN icon
Align Technology
ALGN
+$6.85M
4
CELG
Celgene Corp
CELG
+$4.47M
5
DGX icon
Quest Diagnostics
DGX
+$4.32M

Sector Composition

Rank Sector Weight
1 Healthcare 90.94%
2 Energy 2.02%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
51
Bristol-Myers Squibb
BMY
$130B
– –
-140,000
Closed -$8.69M
BPMC
52
DELISTED
Blueprint Medicines
BPMC
– –
-35,000
Closed -$2.73M
CAH icon
53
Cardinal Health
CAH
$55.9B
– –
-60,000
Closed -$3.24M
CHRS icon
54
Coherus Oncology
CHRS
$187M
– –
-99,101
Closed -$1.64M
DGX icon
55
Quest Diagnostics
DGX
$26.2B
– –
-40,000
Closed -$4.32M
FMS icon
56
Fresenius Medical Care
FMS
$12.7B
– –
-40,000
Closed -$2.06M
LH icon
57
Labcorp
LH
$26.1B
– –
-17,460
Closed -$2.6M
SEM
58
DELISTED
Select Medical
SEM
– –
-55,680
Closed -$552K
TDOC icon
59
Teladoc Health
TDOC
$1.24B
– –
-27,360
Closed -$2.36M
THC icon
60
Tenet Healthcare
THC
$20.9B
– –
-85,000
Closed -$2.42M
ENDP
61
DELISTED
Endo International plc
ENDP
– –
-120,000
Closed -$2.02M
ALXN
62
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-25,000
Closed -$3.48M
PTLA
63
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-32,802
Closed -$874K
AKRX
64
DELISTED
Akorn Inc
AKRX
– –
-140,000
Closed -$1.82M
AET
65
DELISTED
Aetna Inc
AET
– –
-35,000
Closed -$7.1M
EVHC
66
DELISTED
Envision Healthcare Holdings Inc
EVHC
– –
-45,000
Closed -$2.06M
CELG
67
DELISTED
Celgene Corp
CELG
– –
-50,000
Closed -$4.47M
1 2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q4 2018 Portfolio in Review

As of Q4 2018, Sivik Global Healthcare held 69 positions worth $186M, down 34% from $280M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Sivik Global Healthcare withdrew a net $67.3M in Q4 2018, closing 21 positions and reducing 25 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $8.69M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 91% a quarter earlier, followed by Energy and Financials.

Against the trend, Sivik Global Healthcare opened a new position in State Street SPDR S&P Biotech ETF worth $5.38M.

  • Sivik Global Healthcare's largest Q4 2018 buy was State Street SPDR S&P Biotech ETF: 75,000 shares worth $5.38M.
  • Sivik Global Healthcare added most to Agilent Technologies in Q4 2018, an estimated $2.16M increase.
  • Sivik Global Healthcare's biggest Q4 2018 reduction was GW Pharmaceuticals Plc American Depositary Shares, cutting an estimated $2.95M.
  • Sivik Global Healthcare fully exited Bristol-Myers Squibb in Q4 2018, selling an estimated $8.69M.
  • Sivik Global Healthcare's ten largest holdings make up 38% of its $186M portfolio in Q4 2018.
  • Sivik Global Healthcare opened 7 new positions and closed 21 in Q4 2018.
  • Sivik Global Healthcare's portfolio value fell 34% quarter-over-quarter to $186M.

Based on Sivik Global Healthcare's 13F filing for Q4 2018, filed 12 Feb 2019.